Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Industry Outlook 2017: Pharmaceuticals Part 2 – M&As

Filed Under: Industry, Pharma Tagged With: , , , , , , ,

Long-listed drugs often stem from low molecular drugs that have been an important source of revenue for pharmaceutical manufacturers. Being…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Chemical and Material Companies Look to Take Pharmaceutical Operations to the Next Stage
Chemical and Material Companies Look to Take Pharmaceutical…
Asahi Kasei Pursues M&A to Grow Pharmaceuticals Business in Europe
Asahi Kasei Pursues M&A to Grow Pharmaceuticals Business…
Asahi Kasei Advances Into Market for Drug Delivery Systems
Asahi Kasei Advances Into Market for Drug Delivery Systems
Sumitomo Chemical Plans Silicon Valley Startup Support Hub
Sumitomo Chemical Plans Silicon Valley Startup Support Hub
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…